| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Please See Remarks
2 companies
Mock James M is a Chief Financial Officer at MRNA, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 26 sales. Those positions are worth an estimated $4.0M at current prices.
Our model assigns Mock James M a strong insider score of 85/100, based on 14 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +60.2%.
Mock James M's largest disclosed position is in RVTY as Please See Remarks, worth about $4.0M. The recent filings there lean toward selling, a net 16,728 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 29, 2024 | MRNA Moderna, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 647 | $94.57 | $61,188.08 | -13.1% | +60.4% | -66.4% | |
| Jan 8, 2024 | MRNA Moderna, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 772 | $109.75 | $84,730.55 | -17.5% | -8.9% | -58.8% | |
| Oct 6, 2023 | MRNA Moderna, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 2,858 | $102.50 | $292,952.72 | -49.2% | +4.6% | -42.0% | |
| Jun 24, 2022 | RVTY Revvity, Inc. | Please See Remarks | Sell | 5,025 | $145.49 | $731,092.42 | -15.4% | -15.3% | -20.2% | |
| Sep 20, 2021 | RVTY Revvity, Inc. | Please See Remarks | Sell | 6,080 | $184.87 | $1,124,039.89 | -20.7% | +2.4% | -30.4% | |
| Oct 2, 2020 | RVTY Revvity, Inc. | Please See Remarks | Sell | 5,623 | $124.41 | $699,584.34 | -17.1% | - | - |